“I place a high premium on customer service, and that starts with me. I insist that patients are seen on time, and that wait times for consultations and treatment start times are as short as possible. We are dealing with cancer, after all. At VCS we have the best of both worlds (private practice with close personal attention and also academic with cutting edge research and treatment options).”
Radiation Oncology
American Board of Radiology
University of Chicago
St. Joseph Mercy Hospital
University of Chicago
University of Michigan
Breast cancer, prostate cancer, lung cancer, Radiation Oncology
Dr. Gregory S. Sibley joined Virginia Cancer Specialists after 14 years in Radiation Oncology at Sibley Memorial Hospital in Washington, D.C. Throughout his career, Dr. Sibley has focused on providing the highest quality care in the field of radiation oncology. He has positioned himself as an expert in the multi-disciplinary treatment of cancer and in state-of-the-art radiation treatment planning techniques. Within the US Oncology Network, Dr. Sibley is a member of the Executive Committee for Radiation Oncology and Vice-Chair for the Technology Committee. Dr. Sibley has authored over 20 peer-reviewed publications, many while on faculty at Duke University Medical Center. Although well-versed in the treatment of multiple cancers, Dr. Sibley has special interest in breast cancer, brachytherapy for prostate cancer, and intensity-modulated radiotherapy for head and neck, and lung cancers.
In his spare time, Dr. Sibley is an avid hockey player and triathlete.
Virginia Cancer Specialists has earned the prestigious Accreditation Program for Excellence (APEx)
Read MoreBronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?
Read MoreRoutine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer
Read More73.6 Gy and Beyond: hyperfractionated, accelerated radiotherapy for non-small cell lung cancer
Read MoreCan we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?
Read MoreCarboplatin/Paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiotherapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium
Read MoreThe role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests
Read MoreCan angiotensin-converting enzyme inhibitors protect against symptomatic radiation pneumonitis?
Read MoreA new three-dimensional dose distribution reduction scheme for tubular organs
Read MoreThe rationale and use of three-dimensional radiation treatment planning for lung cancer
Read MoreA neural network to predict symptomatic lung injury
Read MoreThe effect of patient-specific factors on radiation-induced regional lung injury
Read MoreClinical and dosimetric predictors of radiation-induced esophageal toxicity
Read MoreMultimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects
Read MoreRadiotherapy for patients with medically inoperable stage I non-small cell lung cancer: smaller volumes and higher doses
Read MoreEnhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors
Read MoreRadiotherapy alone for medically inoperable stage I non-small cell lung cancer: the Duke Experience
Read MoreTumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
Read MoreThe Treatment of Stage III Non-Small Cell Lung Cancer Using High-Dose Conformal Radiotherapy
Read MorePatterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory hodgkin’s disease
Read MoreConservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma in the extremities: clinical and radiobiological results
Read MoreThe patterns of failure following total body irradiation and bone marrow transplantation +/- local radiotherapy boost for advanced neuroblastoma
Read MorePatterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy
Read MoreA Comparison of CT-based treatment planning and retrograde urethrography in determining the prostatic apex at simulation
Read More